ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.445,91
0,15%
S&P 500
5.473,17
-0,25%
US Dollar vs BRL
5,454
0,00%
Bitcoin
64.908,91
0,14%
Brent Oil
84,955
-0,06%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) Notícias

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRTC
DataHoraFonteTítuloCódigoCompanhia
20/06/202403:00Business WirePureTech Announces Change of Board RoleNASDAQ:PRTCPureTech Health PLC
18/06/202408:05Business WirePureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamNASDAQ:PRTCPureTech Health PLC
13/06/202417:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
13/06/202414:15Business WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
06/06/202417:39Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
06/06/202413:38Business WirePureTech Health: Result of General MeetingNASDAQ:PRTCPureTech Health PLC
30/05/202409:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRTCPureTech Health PLC
29/05/202409:09Business WirePureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyNASDAQ:PRTCPureTech Health PLC
23/05/202408:00Business WirePureTech to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
21/05/202408:05Business WirePureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionNASDAQ:PRTCPureTech Health PLC
20/05/202408:03Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:PRTCPureTech Health PLC
20/05/202403:00Business WirePureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareNASDAQ:PRTCPureTech Health PLC
09/05/202408:05Business WirePureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual MeetingNASDAQ:PRTCPureTech Health PLC
07/05/202408:05Business WirePureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive AppointmentsNASDAQ:PRTCPureTech Health PLC
25/04/202406:22Business WirePureTech Announces Annual Results for Year Ended December 31, 2023NASDAQ:PRTCPureTech Health PLC
18/04/202403:00Business WirePureTech Health: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
16/04/202408:00Business WirePureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisNASDAQ:PRTCPureTech Health PLC
11/04/202408:00Business WirePureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersNASDAQ:PRTCPureTech Health PLC
09/04/202403:00Business WirePureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management TransitionsNASDAQ:PRTCPureTech Health PLC
19/03/202404:00Business WirePureTech Proposes $100 Million Capital ReturnNASDAQ:PRTCPureTech Health PLC
18/03/202410:52Business WireBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionNASDAQ:PRTCPureTech Health PLC
13/03/202408:00Business WirePureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid LeukemiaNASDAQ:PRTCPureTech Health PLC
27/02/202409:00Business WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
27/02/202404:00Business WirePureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanNASDAQ:PRTCPureTech Health PLC
03/01/202409:00Business WirePureTech to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
22/12/202311:13Business WirePureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 BillionNASDAQ:PRTCPureTech Health PLC
20/12/202304:00Business WirePureTech Year End Update and Outlook for 2024NASDAQ:PRTCPureTech Health PLC
07/12/202308:00Business WirePureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023NASDAQ:PRTCPureTech Health PLC
29/11/202312:17Business WirePureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of SchizophreniaNASDAQ:PRTCPureTech Health PLC
17/11/202304:00Business WirePureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNASDAQ:PRTCPureTech Health PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRTC

Seu Histórico Recente

LSE
PMH
BIT
SPLG5S
Societe Generale Effekten
BIT
P77104
BNP Paribas
LSE
QK99
Morg.st.b.v 25
BOV
WLMM4Q
WLM PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados